Literature DB >> 428825

Serum bilirubin: a prognostic factor in primary biliary cirrhosis.

J M Shapiro, H Smith, F Schaffner.   

Abstract

We followed up 55 patients with proven primary biliary cirrhosis for several years or until death. A graph of the level of serum bilirubin versus time that was constructed for each patient shows an initial period of variable length in which the serum bilirubin level remained constant. This was followed by a period of rapid rise in serum bilirubin which culminated in the patient's death. Whenever two successive serum bilirubin values taken six months apart exceeded 34 mumol/l (2.0 mg/dl) the patient had entered a late phase of disease and lived an average of 49 months. Ninety-five per cent confidence limits on survival time were 32-74 months. If two successive six month bilirubin values exceeded 102 mumol/l (6.0 mg/dl), calculated survival time was 25 months, and if two successive six month bilirubin values exceeded 170 mumol/l (10.0 mg/dl), survival time was 17 months. Fifteen of the 41 living patients had two consecutive serum bilirubin levels greater than 34 mumol/l (2.0 mg/dl). However, the slope of the rising bilirubin in the living patients is only 35 mumol/l/yr (1.5 mg/dl/yr) compared with 42 mumol/l/yr (2.5 mg/dl/yr) in the dead patients. This means that patients with this disease not may be living considerably longer.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428825      PMCID: PMC1419455          DOI: 10.1136/gut.20.2.137

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  RELATION BETWEEN CIRRHOSIS AND TRACE METAL CONTENT OF LIVER WITH SPECIAL REFERENCE TO PRIMARY BILIARY CIRRHOSIS AND COPPER.

Authors:  A H HUNT; R M PARR; D M TAYLOR; N G TROTT
Journal:  Br Med J       Date:  1963-12-14

Review 2.  COPPER METABOLISM IN NORMAL SUBJECTS.

Authors:  G E Cartwright; M M Wintrobe
Journal:  Am J Clin Nutr       Date:  1964-04       Impact factor: 7.045

3.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

4.  Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.

Authors:  T B Deering; E R Dickson; C R Fleming; M G Geall; J T McCall; A H Baggenstoss
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

5.  Acute copper sulfate poisoning.

Authors:  H K Chuttani; P S Gupta; S Gulati; D N Gupta
Journal:  Am J Med       Date:  1965-11       Impact factor: 4.965

Review 6.  Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).

Authors:  I Sternlieb
Journal:  Prog Liver Dis       Date:  1972

7.  A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.

Authors:  S Jain; P J Scheuer; S Samourian; J O McGee
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

8.  Is primary biliary cirrhosis an immune complex disease?

Authors:  H C Thomas; B J Potter; S Sherlock
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

  8 in total
  48 in total

Review 1.  Primary biliary cirrhosis: new perspectives in diagnosis and treatment.

Authors:  M I Prince; D E Jones
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 3.  Predicting the prognosis of primary biliary cirrhosis.

Authors:  J M Neuberger
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

4.  The ursodeoxycholic acid story in primary biliary cirrhosis.

Authors:  A G Lim; R P Jazrawi; T C Northfield
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

5.  Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis.

Authors:  C J Goddard; A Smith; J A Hoyland; P Baird; R F McMahon; A J Freemont; M Shomaf; N Y Haboubi; T W Warnes
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 6.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

7.  Results of portal decompression in patients with primary biliary cirrhosis.

Authors:  R Spinsi; G Smith-Laing; O Epstein; S Sherlock
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

8.  Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.

Authors:  Meri Koulentaki; Joanna Moscandrea; Philipos Dimoulios; Costas Chatzicostas; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

9.  Role of plasmapheresis in primary biliary cirrhosis.

Authors:  L B Cohen; E P Ambinder; A M Wolke; S P Field; F Schaffner
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.